- Stocks
- Healthcare
- NYSEAMERICAN: MLSS

Price (delayed)

$0.868

Market cap

$67.03M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.1

Enterprise value

$63.4M

Milestone Scientific Inc. is a biomedical technology research and development company that patents, designs and develops innovative diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic and veterinary

The debt has contracted by 22% YoY and by 7% from the previous quarter

The company's gross margin rose by 18% YoY

The gross profit is up by 29% year-on-year but it has declined by 3.1% since the previous quarter

The revenue is up by 9% year-on-year but it is down by 3.5% since the previous quarter

The company's quick ratio fell by 46% YoY and by 24% QoQ

The equity has contracted by 21% YoY and by 7% from the previous quarter

Sector: Healthcare

Industry: Medical Instruments & Supplies

Website: http://www.milestonescientific.com

What are the main financial stats of MLSS

Market
Valuations
Earnings

Shares outstanding

77.23M

Market cap

$67.03M

Enterprise value

$63.4M

Price to earnings (P/E)

N/A

Price to book (P/B)

8.91

Price to sales (P/S)

7.3

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

6.69

Revenue

$9.48M

EBIT

-$7.23M

EBITDA

-$7.09M

Free cash flow

-$4.54M

Per share
Balance sheet
Liquidity

EPS

-$0.1

Free cash flow per share

-$0.06

Book value per share

$0.1

Revenue per share

$0.12

TBVPS

$0.14

Total assets

$11.35M

Total liabilities

$3.89M

Debt

$369,348

Equity

$7.46M

Working capital

$7.18M

Debt to equity

0.05

Current ratio

2.97

Quick ratio

1.56

Net debt/EBITDA

0.51

Margins
Efficiency
Dividend

EBITDA margin

-74.8%

Gross margin

69.4%

Net margin

-74.5%

Operating margin

-76.3%

Return on assets

-63.5%

Return on equity

-92.1%

Return on invested capital

-149.1%

Return on capital employed

-93.8%

Return on sales

-76.3%

Dividend yield

N/A

DPS

N/A

Payout ratio

N/A

How has the Milestone Scientific stock price performed over time

Intraday

2.12%

1 week

-9.58%

1 month

29.55%

1 year

-21.8%

YTD

25.82%

QTD

27.65%

How have Milestone Scientific's revenue and profit performed over time

Revenue

$9.48M

Gross profit

$6.58M

Operating income

-$7.23M

Net income

-$7.06M

Gross margin

69.4%

Net margin

-74.5%

The gross profit is up by 29% year-on-year but it has declined by 3.1% since the previous quarter

The net margin has grown by 20% YoY but it has contracted by 6% from the previous quarter

The operating margin has increased by 20% year-on-year but it has declined by 6% since the previous quarter

The company's gross margin rose by 18% YoY

What is Milestone Scientific's growth rate over time

What is Milestone Scientific stock price valuation

P/E

N/A

P/B

8.91

P/S

7.3

EV/EBIT

N/A

EV/EBITDA

N/A

EV/Sales

6.69

Milestone Scientific's EPS has increased by 9% YoY

The P/B is 39% lower than the 5-year quarterly average of 14.7 but 22% higher than the last 4 quarters average of 7.3

The equity has contracted by 21% YoY and by 7% from the previous quarter

The P/S is 37% less than the 5-year quarterly average of 11.5 but 24% more than the last 4 quarters average of 5.9

The revenue is up by 9% year-on-year but it is down by 3.5% since the previous quarter

How efficient is Milestone Scientific business performance

The company's return on invested capital rose by 36% YoY but it fell by 22% QoQ

The return on equity has declined by 25% year-on-year and by 9% since the previous quarter

Milestone Scientific's ROS has increased by 19% YoY but it has decreased by 6% from the previous quarter

MLSS's ROA is down by 13% YoY and by 3.9% QoQ

What is MLSS's dividend

DPS

N/A

Dividend yield

N/A

Payout ratio

N/A

There are no recent dividends present for MLSS.

How did Milestone Scientific financials performed over time

The total assets is 192% greater than the total liabilities

The company's quick ratio fell by 46% YoY and by 24% QoQ

Milestone Scientific's current ratio has decreased by 32% YoY and by 15% from the previous quarter

The debt is 95% less than the equity

The debt has contracted by 22% YoY and by 7% from the previous quarter

The equity has contracted by 21% YoY and by 7% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.